Literature DB >> 23264127

Successful transplantation of ethnically mismatched cord blood in a boy with atypical chronic myeloid leukemia.

Tang-Her Jaing1, Iou-Jih Hung, Shih-Hsiang Chen, Wen-I Lee, Yu-Chuan Wen, En-Chen Fang.   

Abstract

In the present study, we describe unrelated umbilical cord blood transplantation (CBT) in a 7-year-old Taiwanese boy with atypical chronic myeloid leukemia (BCR-ABL 1 negative). Physical examination was notable for splenomegaly. Cytogenetic analyses from the bone marrow revealed a t(3;5)(p21;q31) translocation. The patient then underwent CBT from an HLA-mismatched (two loci by serotype, three loci by genotype) unrelated donor of Caucasian origin. Times to neutrophil and platelet engraftment were 21 and 62 days post-transplant, respectively. Acute graft-versus-host disease following transplantation was minimal. The patient remains in continuing hematological remission with full donor chimerism 28 months after transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 23264127     DOI: 10.1007/s12185-012-1251-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

Review 1.  World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants.

Authors:  James Vardiman; Elizabeth Hyjek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Adoptive transfer of allogeneic antigen-specific T cells.

Authors:  Stanley R Riddell; Marie Bleakley; Tetsuya Nishida; Carolina Berger; Edus H Warren
Journal:  Biol Blood Marrow Transplant       Date:  2006-01       Impact factor: 5.742

Review 3.  Natural killer cell alloreactivity in allogeneic hematopoietic transplantation.

Authors:  Loredana Ruggeri; Antonella Mancusi; Emanuela Burchielli; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Curr Opin Oncol       Date:  2007-03       Impact factor: 3.645

Review 4.  Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantation.

Authors:  Jeffrey Molldrem; Stanley Riddell
Journal:  Cancer Treat Res       Date:  2009

5.  Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia.

Authors:  M Koldehoff; N K Steckel; Y Hegerfeldt; M Ditschkowski; D W Beelen; A H Elmaagacli
Journal:  Int J Lab Hematol       Date:  2011-06-27       Impact factor: 2.877

6.  Molecular basis of myelodysplastic/myeloproliferative neoplasms.

Authors:  Andreas Reiter; Rosangela Invernizzi; Nicholas C P Cross; Mario Cazzola
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

7.  Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.

Authors:  Jaime Sanz; Pau Montesinos; Silvana Saavedra; Ignacio Lorenzo; Leonor Senent; Dolores Planelles; Luis Larrea; Guillermo Martín; Javier Palau; Isidro Jarque; Jesús Martínez; Javier de la Rubia; Federico Moscardó; David Martinez; Inés Gómez; María López; Miguel A Sanz; Guillermo F Sanz
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-27       Impact factor: 5.742

Review 8.  Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Authors:  James E Talmadge
Journal:  Int Immunopharmacol       Date:  2003-08       Impact factor: 4.932

9.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Authors:  Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

10.  Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.

Authors:  E Joanna Baxter; Shashikant Kulkarni; José-Luis Vizmanos; Rina Jaju; Giovanni Martinelli; Nicoletta Testoni; George Hughes; Zoryana Salamanchuk; Maria José Calasanz; Idoya Lahortiga; Christopher F Pocock; Raymond Dang; Carrie Fidler; James S Wainscoat; Jacqueline Boultwood; Nicholas C P Cross
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.